Clinical trial
A Multi-center, Randomized, Double-blinded, Placebo-controlled, Parallel Phase IIb Clinical Trial for the Efficacy Assessment and Safety Evaluation by Treating CU01-1001 for 24 Weeks in Type 2 Diabetic Nephropathy Patients With Albuminuria
NCT05718375 is registered in ClinicalTrials.gov with Curacle Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double-blinded, Placebo-controlled, Parallel Phase IIb Clinical Trial for the Efficacy Assessment and Safety Evaluation by Treating CU01-1001 for 24 Weeks in Type 2 Diabetic Nephropathy Patients With Albuminuria
- Lead sponsor
- Curacle Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 14, 2023
- Completion date
- November 12, 2025
- Enrollment
- 240 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.